Marshall BioResources

Active — Near Monopoly
North Rose, New York — Global operations: US, UK, France, China, Italy, Japan
~23,000 dogsFounded 1939Beagle colony since 196220+ USDA violationsWorld's largest breeder

USDA AWA Violations

Marshall BioResources has been cited for more than 20 Animal Welfare Act violations since 2007, documented by USDA APHIS inspectors and compiled by Rise for Animals. The violations span nearly two decades of inspections at the North Rose, New York facility.

Data Gap
Unlike Envigo (where DOJ filings enumerated 70+ specific violations) or Ridglan (where 311 DATCP violations were documented in state records), Marshall's specific violation details are less accessible in public sources. USDA APHIS inspection reports can be requested via FOIA but are not as thoroughly reported in public investigative journalism. Rise for Animals has done the most comprehensive public compilation.

The Enforcement Gap

The contrast between Marshall's enforcement history and that of other facilities raises questions about USDA inspection consistency:

Envigo: 70+ violations → Federal shutdown + $35M fine
DOJ civil complaint, criminal guilty plea, permanent prohibition on licensed activity, largest AWA penalty in history.
Ridglan: 311 violations → License surrender
State-level DATCP enforcement, settlement requiring USDA license surrender by July 2026, 200+ beagles rescued.
Marshall: 20+ violations → No comparable action
Despite nearly two decades of documented violations, Marshall has never faced enforcement action on the scale of Envigo or Ridglan. Continues to operate as the world's largest beagle breeder.
Key Finding
The enforcement gap may be partly explained by Marshall's monopoly position. With Envigo closed and Ridglan closing, aggressive enforcement against Marshall would disrupt the entire US research dog supply chain. USDA may face an implicit conflict: enforce compliance standards vs. maintain supply for the research industry it also serves.

Copenhagen Route Investigation (2023)

A 2023 investigative exposé documented that over 6,000 beagles had been transported on SAS passenger flights from Marshall's US facility through Copenhagen Airport, then distributed to laboratories in seven European countries.

Key findings:
  • 6,000+ beagles documented as shipped via this single route
  • Dogs traveled as cargo on SAS passenger planes
  • Route: North Rose, NY → Copenhagen → UK, Italy, Germany, Netherlands, Spain, Belgium, France
  • Route disrupted following public exposure — no documented shipments afterward
  • Marshall's alternative European shipping routes remain unknown

PETA Investigation

PETA has conducted investigations documenting conditions at Marshall and at Liberty Research, identified as a Marshall-linked facility. Investigation details and published materials are available through PETA's public reporting.

Genetic Evidence

A 2024 study published in Springer Immunogenetics documented that Marshall's colony beagles have restricted DLA class II immune diversity compared to pet beagles. This finding has scientific and regulatory implications:

  • Vaccine and immunology study results from Marshall dogs may not generalize to pet beagles or other breeds
  • Colony-specific pharmacogenomics (e.g., CYP2D15 polymorphisms) mean drug safety profiles can vary depending on which colony tested them
  • Mean inbreeding coefficient (F_ROH) ~0.031 — structured lineage breeding, not close inbreeding
  • Raises questions about the scientific validity of extrapolating from these genetically narrow populations

Related Evidence